Editorial Comment

Abstract

The authors report a single-institution series of percutaneous transarterial embolization (TAE) in the management of non-neoplastic renal hemorrhage. In their series, they review 41 patients who had undergone TAE for postprocedural (92.7%) and spontaneous (7.3%) bleeding refractory to conservative management. Of the 41 patients, 35 (85.4%) were successfully treated with endovascular embolization and 6 required nephroscopy, open tract exploration, or nephrectomy for definitive treatment. ReplyUrologyVol. 74Issue 3PreviewWe would like to thank the editorial board for their positive reception of our work. Full-Text PDF Management of Non-neoplastic Renal Hemorrhage by Transarterial EmbolizationUrologyVol. 74Issue 3PreviewTo assess the role of transarterial embolization (TAE) and critically appraise its feasibility and efficacy in the management of non-neoplastic renal hemorrhage. Percutaneous TAE is an effective method for the control of hemorrhage, irrespective of the cause. Injury to the renal artery or its branch, after trauma or during open or percutaneous urologic procedures, can be accurately diagnosed using angiography and treated by percutaneous embolization techniques. Because the technique and technology have evolved, it is now possible to perform highly selective embolization of the injured vessel while preserving vascularity of the rest of the renal parenchyma. Full-Text PDF